Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease.

Morris, Michael F; Pershad, Yash; Kang, Paul; Ridenour, Lauren; Lavon, Ben; Lanclus, Maarten; Godon, Rik; De Backer, Jan; Glassberg, Marilyn K

Morris, Michael F; Pershad, Yash; Kang, Paul; Ridenour, Lauren; Lavon, Ben; Lanclus, Maarten; Godon, Rik; De Backer, Jan; Glassberg, Marilyn K.

Afiliação

Morris MF; Dept of Radiology, Banner - University Medical Center Phoenix, Phoenix, AZ, USA michael.morris@bannerhealth.com.
Pershad Y; Dept of Medicine, Banner - University Medical Center Phoenix, Phoenix, AZ, USA.
Kang P; Dept of Bioengineering, Stanford University, Palo Alto, CA, USA.
Ridenour L; Dept of Biostatistics, University of Arizona College of Public Health, Phoenix, AZ, USA.
Lavon B; Dept of Medicine, Banner - University Medical Center Phoenix, Phoenix, AZ, USA.
Lanclus M; FLUIDDA, New York City, NY, USA.
Godon R; FLUIDDA, New York City, NY, USA.
De Backer J; FLUIDDA, New York City, NY, USA.
Glassberg MK; FLUIDDA, New York City, NY, USA.

Eur Respir J ; 58(3)2021 09.

Article em En | MEDLINE | ID: mdl-33632795

Assuntos

COVID-19; Biomarcadores; Volume Sanguíneo; Humanos; Estudos Retrospectivos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google